5.22 USD
↘ 0.03 (0.57%)AT CLOSE (AS OF 08:01 PM EDT)
SELLAS Life Sciences Group, Inc. Common Stock
SLSNASDAQ • USD
Market: CLOSED
Open?$5.22
High?$5.28
Low?$5.03
Prev. Close?$5.25
Volume?5.9M
Avg. Volume?4.7M
VWAP?$5.17
Rel. Volume?1.26x
Bid / Ask
Bid?$4.48 × 100
Ask?$5.94 × 100
Spread?$1.46
Midpoint?$5.21
Valuation & Ratios
Market Cap?968.8M
Shares Out?184.5M
Float?147.9M
Float %?98.7%
P/E Ratio?N/A
P/B Ratio?13.67
EPS?-$0.15
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Themes
Employees
13
Market Cap
968.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2008-03-12
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Phone: (646) 200-5278
NEW YORK, NY 10036
Phone: (646) 200-5278
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?10.70Strong
Quick Ratio?10.70Strong
Cash Ratio?10.23Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?13.67HIGH▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-31.7CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-37.9%WEAK▾
ROA?-34.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$897.0M
Fundamentals ratios updated end of day